STOCKHOLM, Sweden--(BUSINESS WIRE)--Regulatory News: Biovitrum (STO:BVT) June • Net revenues increased with 33 percent, and amounted to SEK 404.2 M (304.8). Net profit increased and was SEK 59.8 M (7.1). Earnings per share were SEK 1.31 (0.15). The increase is mainly due to the strong development of the ReFacto® manufacturing revenues
